Cardiac pacing: How it started, where we are, where we are going

Journal of Cardiovascular Electrophysiology

Volumn 15, Issue 5, 2004, Pages 619-627

  Hayes, David L ^a,c   Furman, Seymour ^b  

^a MAYO CLINIC   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONGESTIVE HEART FAILURE; ELECTRIC BATTERY; EVOLUTION; HEART ATRIUM FIBRILLATION; HEART MUSCLE POTENTIAL; HEART PACING; HISTORY OF MEDICINE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MORBIDITY; MORTALITY; NOMENCLATURE; NONHUMAN; PACEMAKER ELECTRODE; PREDICTION; PRIORITY JOURNAL; REVIEW; SUDDEN DEATH; SYNCOPE; TELEMETRY; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 2442488878     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2004.04088.x     Document Type: Review

References (61)

1. Zoll PM: Resuscitation of the heart in ventricular standstill by external electric stimulation. N Engl J Med 1952;247:768-771.
2. Zoll PM, Linenthal AJ, Norman LR, Paul MH, Gibson W: Treatment of unexpected cardiac arrest by external electric stimulation of the heart. N Engl J Med 1956;254:541-546.
3. Zoll PM, Linenthal AJ, Norman LR, Paul MH, Gibson W: Treatment of unexpected cardiac arrest by external electric stimulation of the heart N Engl J Med 1956;254:541-546.
4. Furman S: The early history of cardiac pacing. Pacing Clin Electrophysiol 2003;26:2023-2032.
5. Floresco N: Pince Excitatrice. J Physiol Pathol General 1905;7:785-786.
6. Marmorstein M: Contribution a l'etude des excitation electriques localises sur le coeur en rapport avec la topographie de l'innervation du coeur chez le chien. [in French] J Physiol Pathol 1927;25:617-625.
7. Lidwill MC: Cardiac disease in relation to anaesthesia. Proceedings of the Third Session, Australasian Medical Congress (British Medical Association) Sydney, Australia, September 2-7, 1929, pp. 160.
8. Hyman AS: Resuscitation of the stopped heart by intracardial therapy. II. Experimental use of an artificial pacemaker. Arch Intern Med 1932;50:283-305.
9. Leatham A, Cook P, Davies JG: External electric stimulator for treatment of ventricular standstill. Lancet 1956;2:1185-1189.
10. Glenn WWL, Mauro A, Longo E, et al: Remote Stimulation of the heart by radio-frequency transmission. N Engl J Med 1959;261:948-951.
11. Abrams LD, Hudson WA, Lightwood R: A surgical approach to the management of heart-block using an inductive coupled artificial cardiac pacemaker. Lancet 1960;1:1372-1374.
12. Siddons AHM: Long-term artificial cardiac pacing: Experience in adults with heart block. Ann Roy Coll Surg Eng 1963;32:22-41.
13. Chardack WM, Gage AA, Greatbatch W: A transistorized, self-contained implantable pacemaker for the long-term correction of complete heart block. Surgery 1960;48:643-654.
14. Hunter SW, Roth NA: The platform bipolar myocardial electrode for prolonged treatment of total heart block. Lancet 1961;81:115-117.
15. Zoll PM, Frank HA, Zarsky LR, et al: Long-term electrical stimulation of the heart for Stokes-Adams disease. Ann Surg 1961;154:330-346.
16. Kantrowitz A, Cohen R, Raillard H, et al: The treatment of complete heart block with an implanted controllable pacemaker. Surg Gynecol Obstet 1962;115:415-420.
17. Ruben S, inventor: US Patent 2,422,045. 1947.
18. Greatbatch W, Lee JH, Mathias W, Eldridge M, Moser JR, Schneider AA: The solid-state lithium battery: A new improved chemical power source for implantable cardiac pacemakers. IEEE Trans Biomed Eng 1971;18:317-323.
19. Nathan DA, Center S, Wu C-Y, Keller W: An implantable synchronous pacemaker for the long term correction of complete heart block. Circulation 1963;27:682-685.
20. Funke HD: Optimized sequential pacing of atria and ventricles: A new concept in treatment of bradycardiac dysrhythmias. [in German] Herz Kreislauf 1978;10:479-483.
21. Aubert AE, Ector H: New lead technology for the 21st century. In Antonioli GE, ed: Pacemaker Leads. Bologna, Italy: Monduzzi, 1997, pp. 17-24.
22. Furman S: Pacemaker programmability. Pacing Clin Electrophysiol 1978;1:161-162.
23. Chardack WM, Gage AA, Federico AJ, et al: Five years' clinical experience with an implantable pacemaker: An appraisal. Surgery 1965;58:915-922.
24. Kantrowitz A, Cohen R, Raillard H, et al: The treatment of complete heart block with an implanted controllable pacemaker. Surg Gynecol Obstet 1962;115:415-420.
25. Parsonnet V, Cuddy TE, Escher DJW, Furman S, Morse D, Gilbert L, Zucker IR: A pacemaker capable of external non-invasive programming. Trans Am Soc Artif Intern Organs 1973;19:224-228.
26. Samet P, Bernstein WH, Nathan DA, Lopez A: Atrial contribution to cardiac output in complete heart block. Am J Cardiol 1965;16:1-10.
27. Benchimol A, Duenas A, Liggett MS, Dimond EG: Contribution of atrial systole to the cardiac function at a fixed and at a variable ventricular rate. Am J Cardiol 1965;16:11-21.
28. Karlof I: Haemodynamic effect of atrial triggered versus fixed rate pacing at rest and during exercise in complete heart block. Acta Med Scand 1975;197:195-206.
29. Humen DP, Kostuk WJ, Klein GJ: Activity-sensing rate-responsive pacing: Improvement in myocardial performance with exercise. Pacing Clin Electrophysiol 1985;8:52-59.
30. Alt E, Heinz M, Hirgstetter C, et al: Control of pacemaker rate by impedance-based respiratory minute ventilation. Chest 1987;92:247-252.
31. Rickards AF, Donaldson RM, Thalen HJ: The use of QT interval to determine pacing rate: Early clinical experience. Pacing Clin Electrophysiol 1983;6:346-356.
32. Mahaux V, Waleffe A, Kulbertus HE: Clinical experience with a new activity sensing rate modulated pacemaker using autoprogrammability. Pacing Clin Electrophysiol 1990;13:819-820.
33. Parsonnet V, Furman S, Smyth NPD: Implantable cardiac pacemakers. Status report and resource guideline: Pacemaker study group. Circulation 1974;50:A-21-A-35.
34. Bernstein AD, Daubert JC, Fletcher RD, et al: The revised NASPE/BPEG generic code of antibradycardia, adaptive-rate, and multisite pacing. North American Society of Pacing and Electrophysiology/British Pacing and Electrophysiology Group. Pacing Clin Electrophysiol 2002;25:260-264.
35. Gregoratos G, Abrams J, Epstein AE, et al: ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002;106:2145.
36. Andersen HR, Nielsen JC, Thomsen PE, et al: Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997;350:1210.
37. Lamas GA, Orav EJ, Stambler BS, et al: Pacemaker selection in the elderly investigators: Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. N Engl J Med 1998;338:1097.
38. Connolly SJ, Kerr CR, Gent M, et al: Canadian Trial of Physiologic Pacing Investigators: Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 2000;342:1385.
39. Lamas GA, Lee KL, Sweeney MO, et al: Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002;346:1854.
40. Toff WD, Skehan JD, De Bono DP, et al: The United Kingdom Pacing and Cardiovascular Events (UKPACE) trial: United Kingdom Pacing and Cardiovascular Events. Heart 1997;78:221.
41. Connolly SJ, Sheldon R, Roberts RS, et al: The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999;33:16-20.
42. Sutton R, Brognole M, Menozzi C, et al: Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: Pacemaker versus no therapy: A multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators. Circulation 2000;102:294-299.
43. Connolly SJ, Sheldon R, Thorpe KE, et al: Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second vasovagal pacemaker study (VPS II): A randomized trial. JAMA 2003;289:2272-2275.
44. Fananapazir L, Epstein ND, Curiel RV, et al: Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994;90:2731-2742.
45. Nishimura RA, Trusty JM, Hayes DL, et al: Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double-blind crossover trial. J Am Coll Cardiol 1997;29:435-441.
46. Kappenberger L, Linde C, Daubert C, et al, and the PIC Study Group: Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. Eur Heart J 1997;18:1249-1256.
47. Maron BJ, Nishimura RA, McKenna WJ, et al: Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation 1999;99:2927-2933.
48. Maron BJ, Shen WK, Link MS, et al: Efficacy of implantmable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000;342:422-424.
49. Cazeau S, Ritter P, Bakdach S, et al: Four chamber pacing in dilated cardiomyopathy. Pacing Clin Electrophysiol 1994;17:1974-1979.
50. Abraham WT, Hayes DL: Cardiac resynchronization therapy for heart failure. Circulation 2003;108:2596-2603.
51. Auricchio A, Stellbrink C, Sack S: Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-2033.
52. Cazeau S, Leclercq C, Lavergne T, et al: Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-880.
53. Abraham WT, Fisher WG, Smith AL, et al: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1902-1905.
54. Young JB, Abraham JS, Smith AL, et al: Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003;289:2685-2694.
55. Thackray S, Coletta A, Jones P, et al: Clinical trials update: Highlights of the Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHF. Eur J Heart Fail 2001;3:491-494.
56. Bristow MR, Feldman AM, Saxon LA: Heart failure management using implantable devices for ventricular resynchronization: Comparison of medical therapy, pacing and defibrillation in chronic heart failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators. J Card Fail 2000;6:276-285.
57. Cleland JG, Daubert JC, Erdmann E, et al: The CARE-HF study (Cardiac Resynchronisation in Heart Failure study): Rationale, design and end-points. Eur J Heart Fail 2001;3:481-489.
58. Yu CM, Lin H, Zhang Q, et al: High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart 2003;89:54-60.
59. Saksena S, Prakash A, Ziegler P, et al: Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol 2002;40:1140-1150.
60. Carlson MD, Messenger J, Beau S, et al: A new pacemaker algorithm for the treatment of atrial fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT) J Am Coll Cardiol 2003;42:627-633.
61. Lee MA, Weachter R, Pollak S, et al: The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency results of a randomized trial in patients with bradycardiac and atrial tachyarrhythmias. J Am Coll Cardiol 2003;41:1926-1932.